Bioactivity:

TAK285-IODO, similar to TAK285 in which the trifluoro group is replaced by iodo, is a novel dual erbB protein kinase inhibitor that specifically targets human epidermal growth factor receptor (EGFR) and HER2.

CAS nr:

T34775

Purity:

98%

Molecular Weight:

605,86

SMILES:

CC(O)(CC(NCCN1C=CC2=NC=NC(NC3=CC=C(C(Cl)=C3)OC4=CC=CC(I)=C4)=C21)=O)C

Formula:

C25H25ClIN5O3

Pathway:

Target: